ARID5A and colorectal carcinoma: Recently, the expression levels of Arid5a have been reported to be significantly increased in mesenchymal tumor subtypes of PDAC and CRC, such as the quasi-mesenchymal and consensus molecular subtype 4 subtypes, respectively [206].